Urogen Pharma (NASDAQ:URGN) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Urogen Pharma (NASDAQ:URGN - Get Free Report) have earned an average rating of "Moderate Buy" from the eight ratings firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned...